Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Gross Profit (2021 - 2025)

PAVmed has reported Gross Profit over the past 5 years, most recently at -$703000.0 for Q4 2025.

  • Quarterly results put Gross Profit at -$703000.0 for Q4 2025, down 384.83% from a year ago — trailing twelve months through Dec 2025 was -$1.0 million (up 93.52% YoY), and the annual figure for FY2025 was -$817000.0, up 90.54%.
  • Gross Profit for Q4 2025 was -$703000.0 at PAVmed, down from -$50000.0 in the prior quarter.
  • Over the last five years, Gross Profit for PAVM hit a ceiling of $56000.0 in Q3 2021 and a floor of -$11.7 million in Q4 2023.
  • Median Gross Profit over the past 5 years was -$695000.0 (2024), compared with a mean of -$2.1 million.
  • Biggest five-year swings in Gross Profit: crashed 8421.43% in 2022 and later surged 98.76% in 2024.
  • PAVmed's Gross Profit stood at -$141000.0 in 2021, then plummeted by 3904.96% to -$5.6 million in 2022, then tumbled by 107.63% to -$11.7 million in 2023, then surged by 98.76% to -$145000.0 in 2024, then tumbled by 384.83% to -$703000.0 in 2025.
  • The last three reported values for Gross Profit were -$703000.0 (Q4 2025), -$50000.0 (Q3 2025), and -$35000.0 (Q2 2025) per Business Quant data.